Lignocainum Jelfa (Lidocaine Hydrochloride)

Lidocaine works by reversibly blocking voltage‑gated sodium channels on nerve cells. This inhibition prevents the rapid influx of sodium ions needed for depolarization, thereby stopping the transmission of pain signals along the nerve fibers in the treated area.

The appropriate dose of Lignocainum Jelfa is determined by the prescribing healthcare professional based on the specific procedure, patient characteristics, and clinical guidelines. The prescriber will calculate the volume required to achieve effective urethral anesthesia while staying within safety limits.

Safety data for lidocaine use in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss potential risks with the patient.

To order Lignocainum Jelfa, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Lignocainum Jelfa contains lidocaine, an amide‑type local anesthetic known for rapid onset and moderate duration of action. Compared with ester‑type agents such as procaine, lidocaine generally offers a faster onset, longer duration, and lower risk of allergic reactions, making it a preferred choice for urethral procedures.

Lignocainum Jelfa should be stored at ambient temperature, protected from direct light and moisture. Keep the product in its original sealed container until use, and avoid exposing it to extreme temperatures or humidity to maintain sterility and potency.

The solution is applied directly to the urethral mucosa by a qualified healthcare professional. It is typically instilled using a sterile catheter or syringe, allowing the drug to coat the target area before the procedure begins. Administration is performed in a controlled clinical setting.

The most serious risks include systemic toxicity leading to central nervous system effects such as seizures, cardiac arrhythmias, severe allergic reactions (anaphylaxis), and rare cases of methemoglobinemia. Prompt recognition of symptoms and immediate medical intervention are essential if these events occur.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid using Lignocainum Jelfa. Additionally, individuals with severe cardiac conduction disorders, uncontrolled epilepsy, or those taking medications that significantly raise lidocaine levels should be evaluated carefully before use.